Coherus Oncology
CHRS
CHRS
201 hedge funds and large institutions have $1.58B invested in Coherus Oncology in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 61 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.12% less ownership
Funds ownership: 122.37% → 120.25% (-2.1%)
75% less call options, than puts
Call options by funds: $742K | Put options by funds: $2.98M
Holders
201
Holding in Top 10
2
Calls
$742K
Puts
$2.98M
Top Buyers
| 1 | +$56.7M | |
| 2 | +$11.9M | |
| 3 | +$8.66M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$7.26M |
| 5 |
ACB
Aristotle Capital Boston
Boston,
Massachusetts
|
+$5.91M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$26.9M | |
| 3 | -$18.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$16.2M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.35M |